Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAN016 in Advanced Solid Tumors
NCT07664150Phase 2Recruiting
- Sponsor
- Canwell Biotech Ltd.
- Start
- Jun 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of CAN016 in solid tumor, breast cancer, sponsored by Canwell Biotech Ltd.. Started Jun 2026; status: recruiting.
02
Drugs
CAN016
03
Conditions
solid tumorbreast cancer
Beyond the preview
Go deeper on NCT07664150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07664150.